The present study explored the hypothesis that increased tubular expression of PARP-1 contributes to delayed renal function in suboptimal ECD kidney allografts and in non-ECD allografts that develop posttransplant acute tubular necrosis (ATN).
If renal function is suboptimal and an FDG PET/CT examination with intravenous CT contrast agent is necessary, then the referring physician can initiate the protocol for prevention of nephrotoxicity (hydrate the patient and repeat the blood test, and if necessary prescribe medication for prevention of nephrotoxicity).
His renal function was probably suboptimal following drug administration, resulting in markedly elevated AUC for free platinum compared with patients treated at the same dose level.
The importance to control fluid balance and to limit fluid overload in post operative cardiac surgery patients has been clearly demonstrated in several retrospective studies that have associated fluid overload to suboptimal outcomes (in terms of cardiac, pulmonary and renal function) [ 4- 7].
However, suboptimal uric acid control has been associated with worsening renal function [ 10- 12].
Higher risk is associated with the following age-related changes: decreased renal function, slowed hormonal regulation and counter-regulation, suboptimal hydration, and slowed intestinal functioning (absorption).
77 Febuxostat (80 240 mg daily) was more effective than potentially suboptimal doses of allopurinol (300 mg in patients with normal renal function, 100 200 mg if renal insufficiency) in lowering SUA, with a similar overall safety profile.
Suboptimal response is defined as follows: Atypical HUS: failure to correct thrombocytopenia and/or to improve renal function at day 5 of standard treatment Acquired TTP: PC not doubled by day 5 of standard treatment or diseaseprogression (increased thrombocytopenia or onset of organ damage) duringintensive first-line treatment or on reducing the frequency of PE (strong agreement).
People with unmonitored renal function do worse that those who are monitored and appear to receive suboptimal medical therapies.
Suboptimal response is defined as follows: – Atypical HUS: failure to correct thrombocytopenia and/or to improve renal function at day 5 of standard treatment – Acquired TTP: PC not doubled by day 5 of standard treatment or diseaseprogression (increased thrombocytopenia or onset of organ damage) duringintensive first-line treatment or on reducing the frequency of PE (strong agreement).
However, aminoglycosides are suboptimal for lung tissue penetration [ 32] and have adverse effects on auditory [ 33] and renal function [ 34, 35].
